NBY
NBY
AMEX · Pharmaceuticals

Novabay Pharmaceuticals Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$1.45
-0.05 (-3.33%)
As of Mar 25, 4:25 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +1,870.3% upside
Low Target $17.04
Average Target $28.57
High Target $34.41
Current Price $1.45
Current
$1.45
Target
$28.57
$17.04 $28.57 avg $34.41
Scenario Analysis
Bear Case
$17.04
1,075.2%
Low target
Base Case
$28.57
+1,870.3%
Avg target
Bull Case
$34.41
+2,273.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$99.75
-98.5% from high
52-Week Low
$1.11
+30.6% from low
Target vs 52W High
$28.57
-71.4% vs high
Next Earnings Report
Mar 31, 2026 · After Market Close
4d
until earnings
EPS Est: $-0.20
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%